Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. PSKY
3. META
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. LXEO
10. MONRY

Go back to Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.33 -0.75 (1.47%)
Previous Close $51.08    52 Week High $45.58 
Open $50.69    52 Week Low $37.82 
Day High $50.71    P/E N/A 
Day Low $50.22    EPS $0.00 
Volume 699,663       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.33 -0.75 (1.47%)
Previous Close $51.08    52 Week High $45.58 
Open $50.69    52 Week Low $37.82 
Day High $50.71    P/E N/A 
Day Low $50.22    EPS $0.00 
Volume 699,663       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.38 +0.24 (21.05%)
Previous Close $1.14    52 Week High $3.85 
Open $1.30    52 Week Low $1.25 
Day High $1.40    P/E N/A 
Day Low $1.28    EPS $-0.28 
Volume 2,892,278